The global infertility treatment devices market size reached USD 474.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 761.7 Million by 2033, exhibiting a growth rate (CAGR) of 5.12% during 2025-2033. The rising infertility rates, ongoing technological advancements, the growing trend of delayed parenthood, and numerous government initiatives are primarily driving the market's growth.
Infertility is a disease of the male or female reproductive system wherein attempts to achieve pregnancy after 12 months or more fail. It is generally caused by problems in the ejection of semen in the male reproductive system or abnormalities in the ovaries, uterus, fallopian tubes, and the endocrine system of the female reproductive system. It is treated using assisted reproductive technology (ART) procedures, such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), and artificial insemination methods like intrauterine insemination (IUI). At present, there is a rise in the demand for infertility treatment devices on account of the rising prevalence of conditions like polycystic ovary syndrome (PCOS) around the world.
Infertility Treatment Devices Market Trends:
The increasing number of fertility clinics across the globe represents one of the key factors propelling the growth of the market. Moreover, lack of physical activities on account of sedentary lifestyles has led to the development of chronic diseases, such as diabetes, obesity, and hypertension, which are potential risk factors leading to infertility among men and women. Consequently, there is a rise in the use of ART procedures, such as IVF, which involves the utilization of previously frozen embryos and donor eggs or sperm. This, coupled with the growing availability of numerous infertility treatment devices, is positively influencing the market. Apart from this, key players are introducing technological advancements and developing techniques that improve the conception success rate. They are also increasingly focusing on strategic developments, agreements/partnerships with domestic players, geographical expansions, and mergers and acquisitions (M&A) to increase their presence and widen their customer-base. Some of the other factors contributing to the market growth include declining fertility rates, rising public-private investments and government initiatives to increase the accessibility of infertility treatments.
Key Market Segmentation:
Breakup by Type:
Sperm Separation Devices
Ovum Aspiration Pumps
Sperm Analyzer Systems
Micromanipulator Systems
Incubators
Cryosystems
Imaging Systems
Microscopes
Others
Breakup by Patient Type:
Female Infertility Treatment
Male Infertility Treatment
Breakup by End User:
Fertility Clinics
Hospitals and Other Healthcare Facilities
Clinical Research Institutes
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ab Scientific Ltd, Cook Group Incorporated, Coopersurgical Inc. (The Cooper Companies Inc.), Eppendorf, Esco Micro Pte. Ltd., Genea Limited, Hamilton Throne Ltd., Kitazato Corporation, Rocket Medical plc, Thermo Fisher Scientific, Thomas Medical (Medgyn Products Inc.), Vitrolife.
Key Questions Answered in This Report
1.How big is the infertility treatment devices market?
2.What is the future outlook of infertility treatment devices market?
3.What are the key factors driving the infertility treatment devices market?
4.Which region accounts for the largest infertility treatment devices market share?
5.Which are the leading companies in the global infertility treatment devices market?
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Infertility Treatment Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Sperm Separation Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Ovum Aspiration Pumps
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Sperm Analyzer Systems
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Micromanipulator Systems
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Incubators
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Cryosystems
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Imaging Systems
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Microscopes
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Others
6.9.1 Market Trends
6.9.2 Market Forecast
7 Market Breakup by Patient Type
7.1 Female Infertility Treatment
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Male Infertility Treatment
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End User
8.1 Fertility Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospitals and Other Healthcare Facilities
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinical Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Ab Scientific Ltd
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Cook Group Incorporated
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Coopersurgical Inc. (The Cooper Companies Inc.)